The Genesis Drug Discovery & Development (GD³) company source record lists 9 employees. The visible Genesis Drug Discovery & Development (GD³) management graph includes:
Joyce Huang
Chief Scientific Officer, Chemistry, Genesis Drug Discovery & Development
2
1
General
(4)
Graham Fletcher
Pharmacology and Drug Development Cso
1
0
IT
(1)
Harsh Gautam
Associate in Clinical Database Management Ll Maintaining Comprehensive Databases to Ensure Accurate Data Collection, Integrity, and Analysis for Clinical Trials and Research
0
0
Genesis Drug Discovery & Development (GD³) people graph sample
-
Anthony Rohr
Director of Business Development
Greater Kalamazoo Area, United States3 email signals: 1 email signal on gd3services.com, 2 non-official email signals1 phone signal available
-
Madeline Farley, Ph.d.
Chief Scientific Officer, Biochemistry
Kalamazoo, Michigan, United States3 email signals across 2 non-official domains -
Graham Fletcher
Pharmacology and Drug Development Cso
Trenton, New Jersey, United States1 email signal across 1 non-official domain -
Miglena Prabagar
Plainsboro, New Jersey, United States1 email signal across 1 non-official domain
How AeroLeads builds company intelligence
Use source-backed company records
AeroLeads combines company source fields, workforce samples, email-pattern aggregates, and related-company records when those signals are available.
Show only available evidence
Blank source fields are omitted. Contact channels are summarized as signals, with raw email addresses and phone numbers masked on public pages.
Compare useful company context
Related company, market, workforce, technology, and management signals help turn a static company listing into a company intelligence page.
Contact research
AeroLeads intelligence
Review reachable contact coverage for Genesis Drug Discovery & Development (GD³)
AeroLeads maps 4 visible contact signals for Genesis Drug Discovery & Development (GD³). Coverage is multi-channel contact coverage.